Email Updates

You are here

IPM 014B

Status
Completed
Phase
II
I
Principal Investigator(s)
Dr Annalene Nel
Objective

The purpose of this study is to determine whether dapivirine gel 4789 is safe for daily use by healthy women in South Africa.

Prevention Option(s)
Microbicides
Study Design
Randomized
Arms and Assigned Interventions
Description
dosage: 1.25mg dapivirine/day frequency: once daily duration: 6 weeks
Mode of Delivery
Gel
Products
dapivirine gel
ARMs
Experimental
Description
dosage form: vaginal gel frequency: once daily duration: 6 weeks
Mode of Delivery
Gel
ARMs
Placebo Comparator
Similar Trials
July 2009
September 2009
Enrollment
100
18
Years
40
Years
Population
Women
Sites

Be Part Clinic, Mbekweni

South Africa

Madibeng Centre for Research

Brits
South Africa

Desmond Tutu HIV Foundation - Masiphumelele

Masiphumelele
South Africa